IRCT201107281556N27已完成2 期
Riluzole added to risperidone in the treatment of Autism: A double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 years 至 12 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: 1-DSM IV clinical diagnosis of autistic disorder, 2-children between the ages of 3 and 12 years ,3- presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone)
排除标准
- •1- Presence of any active medical problem, 2-any diagnosis in Axis I and II except for mental retardation, 3-history of allergy to Riluzole,4- receiving any psychotropic medications during past six weeks prior to the trial, 5-presence of hepatic disease, 6-history of seizure
研究者
相似试验
已完成
不适用
Carnosine in the treatment of AutismAutistic Disorder.Childhood autismIRCT201512081556N83Tehran University of Medical Sciences50
尚未招募
2 期
The effect of rosiglitazone in the treatment of autismAutistic disorder.Autistic disorderF84.0IRCT20090117001556N150Tehran University of Medical Sciences50
已完成
2 期
Minocycline in the treatment of autismAutistic Disorder.Childhood autismIRCT201302201556N50Tehran University of Medical Sciences40
已完成
2 期
pioglitazone in the treatment of autismChildhood autism.Childhood autismIRCT201202281556N37Tehran University of Medical Sciences40
尚未招募
2 期
The Efficacy of Risperidone in treatment of Developmental stuttering in Persian adolescents aged 12-18 years oldstuttering.Adult onset fluency disorderF98.5IRCT20240410061463N1Babol University of Medical Sciences30